<?xml version="1.0"?>
<Articles JournalTitle="Iranian Journal of Allergy, Asthma and Immunology">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>0</Volume>
      <Issue>0</Issue>
      <PubDate PubStatus="epublish">
        <Year>2026</Year>
        <Month>04</Month>
        <Day>30</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Exploring Anticancer Potential of Anethum graveolens: Effects on Apoptosis  and HER2 Expression in Human Gastric Adenocarcinoma</title>
    <FirstPage>1</FirstPage>
    <LastPage>11</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Neda</FirstName>
        <LastName>Ahmad Nejad Ahranjani</LastName>
        <affiliation locale="en_US">Department of Biology, Faculty of Basic Sciences, Nabi Akram University, Tabriz, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Maryam</FirstName>
        <LastName>Farghadan</LastName>
        <affiliation locale="en_US">Human and Animal Cell Bank, Iranian Biological Resource Center (IBRC), ACECR, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mehrnoosh</FirstName>
        <LastName>Pashaei</LastName>
        <affiliation locale="en_US">Department of Research Development and Coordination, Deputy for Research and Technology, Ministry of Health and Medical Education, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Sepideh</FirstName>
        <LastName>Ashouri Movassagh</LastName>
        <affiliation locale="en_US">Human and Animal Cell Bank, Iranian Biological Resource Center (IBRC), ACECR, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Seyed Abolhassan</FirstName>
        <LastName>Shahzadeh Fazeli</LastName>
        <affiliation locale="en_US">Department of Genetics, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2025</Year>
        <Month>12</Month>
        <Day>04</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2026</Year>
        <Month>01</Month>
        <Day>31</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Gastric cancer is among the most prevalent malignancies worldwide, with a poor prognosis in advanced stages. Overexpression of human epidermal growth factor receptor 2 (HER2, also known as ERBB2) and heat shock protein 90 alpha (HSP90AA1, also known as HSP90&#x3B1;) has been associated with tumor progression. Anethum graveolens, a medicinal plant from the Apiaceae family, has demonstrated anticancer properties in previous studies. This study aimed to evaluate the effects of A graveolens methanolic extract on apoptosis and the expression of HER2, HSP90&#x3B1;, tumor protein p53 (TP53), and caspase-3 genes in the human gastric adenocarcinoma cell line (AGS).
A methanolic extract of the aerial parts of A graveolens was prepared. Cytotoxicity was assessed in AGS and human gingival fibroblast (HUGU) cell lines using the -(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Gene expression was measured by real-time PCR, and apoptosis was evaluated using Annexin V/propidium iodide (PI) staining followed by flow cytometry.
The methanolic extract exhibited dose-dependent cytotoxicity, with a half-maximal inhibitory concentration (IC50) of 1280 &#x3BC;g/mL in AGS cells. Gene expression analysis revealed significant downregulation of HER2 and upregulation of HSP90&#x3B1;, TP53, and caspase-3 in treated AGS cells compared to controls. Apoptosis rates were significantly higher in treated AGS cells, confirming the proapoptotic effect of the extract. A graveolens exerts cytotoxic and proapoptotic effects in AGS cells and modulates key genes involved in gastric cancer progression.
These findings suggest its potential as a natural therapeutic candidate for gastric cancer, warranting further preclinical and clinical investigations.</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/4687</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/4687/2333</pdf_url>
  </Article>
</Articles>
